{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-048553","form_type":"8-K","ticker":"LABT","cik":"0002079272","company_name":"Lakewood-Amedex Biotherapeutics Inc.","filed_at":"2026-04-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.478573+00:00","generated_at":"2026-05-15T03:17:34.379824+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Appoints Joseph Tucker to board; $6,000/quarter stock + 33,784 warrants at $10","bullets":["Dr. Joseph Tucker appointed to Board, effective April 24, 2026, until 2027 annual meeting.","Compensation: $6,000 per quarter in common stock; granted 33,784 warrants at $10.00, 10-year term.","Warrants vest in 4 equal tranches: Oct 24, 2026; Apr 24, 2027; Oct 24, 2027; Apr 24, 2028.","Tucker is CEO of Enveric Biosciences (NASDAQ: ENVB) with over $100M capital raised track record.","Appointment follows LABT's recent Nasdaq direct listing; Tucker joins Audit, Compensation, Governance committees."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-048553","json":"https://secwatch.observer/filing/0001213900-26-048553.json","markdown":"https://secwatch.observer/filing/0001213900-26-048553.md","text":"https://secwatch.observer/filing/0001213900-26-048553.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2079272/000121390026048553/0001213900-26-048553-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2079272/000121390026048553/ea0287960-8k_lakewood.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T03:17:34.379824+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"27b676567a","claim":"Joseph Tucker was appointed as Director at Lakewood-Amedex Biotherapeutics Inc..","evidence_excerpt":"On April 24, 2026, the Board of Directors (the “Board”) of Lakewood-Amedex Biotherapeutics Inc. (the “Company”) appointed Dr. Joseph Tucker to fill a vacancy and serve as a member of the Board, effective April 24, 2026.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2079272/000121390026048553/0001213900-26-048553-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}